These include Aβ and APP C-terminal fragments in Alzheimer’s disease, altered α-synuclein in Parkinson’s disease, abnormal huntingtin protein in Huntington’s disease, and defective SOD1 and TDP-43 in ALS. This evidence concerns the gene APP and Alzheimer disease.